Background Although each 18 F-fluorodeoxyglucose (FDG) positron emission tomography
(PET) and cardiac magnetic resonance (CMR) imaging with late gadolinium enhancement …

Aims Cardiac death is the leading cause of mortality in patients with sarcoidosis, yet cardiac
involvement often remains undetected. Cardiovascular magnetic resonance imaging (CMR) …

Background Cardiac sarcoidosis (CS) is associated with poor outcomes, but detection
remains difficult. Few studies evaluate 18-fluorodeoxyglucose (18-FDG) positron emission …

Purpose To compare combined cardiac fluorine 18 (18F) fluorodeoxyglucose (FDG)
PET/MRI with standard-of-care evaluation using cardiac MRI, 18F-FDG PET/CT, and SPECT …

AIM To compare combined 2-[18 F]-fluoro-2-deoxy-d-glucose (FDG)-positron-emission
tomography (PET) and cardiac magnetic resonance imaging (CMR) for the diagnosis and …

Objectives The purpose of this study was to investigate the diagnostic value of simultaneous
hybrid cardiac magnetic resonance (CMR) and 18F-fluorodeoxyglucose positron emission …

Objectives: The purpose of this study was to explore the diagnostic usefulness of hybrid
cardiac magnetic resonance (CMR) and positron emission tomography (PET) using 18F …

Though diagnosing cardiac sarcoidosis remains a challenge, knowledge of the clinical entity
has increased over time. The differential diagnosis for a patient with new conduction …

Background Sarcoidosis is a systemic disorder of unknown etiology. It is distinguished by
the presence of noncaseating epithelioid granulomas. This study demonstrates the use of …

Purpose To evaluate the diagnostic and prognostic significance of combined cardiac 18F-
fluorodeoxyglucose (FDG) PET/MRI with T1/T2 mapping in the evaluation of suspected …